Get access

Ribavirin with or without alpha interferon for chronic hepatitis C

  • Withdrawn
  • Review
  • Intervention

Authors

  • Lise Lotte Gluud,

    Corresponding author
    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet,, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    • Lise Lotte Gluud, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet,, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. liselottegluud@yahoo.dk.

    Search for more papers by this author
  • Kim Krogsgaard,

    1. H:S Hvidovre University Hospital 447, PhaseOneTrials A/S, Hvidovre, Denmark
    Search for more papers by this author
  • Christian Gluud

    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet,, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    Search for more papers by this author

Reason for withdrawal from publication

Due to the huge number of trials, this original review is split into two separate reviews: 'Ribavirin monotherapy for chronic hepatitis C' and 'Ribavirin plus interferon versus interferon for chronic hepatitis C'. Both of these reviews are now published in The Cochrane Library.

Get access to the full text of this article

Ancillary